Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
2000; Nature Portfolio; Volume: 6; Issue: 10 Linguagem: Inglês
10.1038/80516
ISSN1546-170X
AutoresBibiana Bielekova, Bonnie L. Goodwin, Nancy Richert, Irene Cortese, Takayuki Kondo, Ghazaleh Afshar, Bruno Gran, J.K. Eaton, Jack P. Antel, Joseph A. Frank, Henry F. McFarland, Roland Martinꝉ,
Tópico(s)Herpesvirus Infections and Treatments
Referência(s)